White Paper
Clinical Development
Life Sciences
adaptive trials
Client Q&A: Achieving success with adaptive clinical trials
MMS Holdings, a CRO that launched an adaptive trial that has undergone 22 mid-study changes with minimal disruptions, shares how it’s overcoming challenges with Zelta.
Related Documents
Datasheet
Zelta Data Integration
Your Trials. Your Choice.
eBook
Driving the speed of adoption with decentralized clinical trials
The evolution of clinical research throughout the pandemic, and beyond
Datasheet
Zelta Endpoint Adjudication Module Brief
Learn more about reducing adjudication timelines with Zelta’s endpoint adjudication module.